.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Citi
Merck
Covington
Chubb
Colorcon
Deloitte
Argus Health
UBS
Novartis

Generated: July 22, 2017

DrugPatentWatch Database Preview

ZYRTEC Drug Profile

« Back to Dashboard

What is the patent landscape for Zyrtec, and what generic Zyrtec alternatives are available?

Zyrtec is a drug marketed by J And J Consumer Inc and is included in four NDAs. There are three patents protecting this drug and three Paragraph IV challenges.

The generic ingredient in ZYRTEC is cetirizine hydrochloride; pseudoephedrine hydrochloride. There are thirty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride; pseudoephedrine hydrochloride profile page.

Summary for Tradename: ZYRTEC

Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: see list108
Clinical Trials: see list27
Patent Applications: see list4,108
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZYRTEC at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
ZYRTEC
cetirizine hydrochloride
SYRUP;ORAL020346-001Sep 27, 1996DISCNNoNo► Subscribe► Subscribe
J And J Consumer Inc
ZYRTEC-D 12 HOUR
cetirizine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL021150-002Nov 9, 2007OTCYesYes7,014,867► SubscribeY ► Subscribe
J And J Consumer Inc
ZYRTEC ALLERGY
cetirizine hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL022578-001Sep 3, 2010OTCYesYes► Subscribe► Subscribe
J And J Consumer Inc
ZYRTEC-D 12 HOUR
cetirizine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL021150-002Nov 9, 2007OTCYesYes7,226,614► Subscribe ► Subscribe
J And J Consumer Inc
ZYRTEC ALLERGY
cetirizine hydrochloride
TABLET;ORAL019835-003Nov 16, 2007OTCYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZYRTEC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc
ZYRTEC
cetirizine hydrochloride
SYRUP;ORAL020346-001Sep 27, 19964,525,358*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ZYRTEC

Drugname Dosage Strength RLD Submissiondate
cetirizine hydrochlorideSyrup5 mg/5 mLZyrtec3/19/2007
cetirizine hydrochlorideChewable Tablets5 mg and 10 mgZyrtec3/25/2005
cetirizine hydrochloride and pseudoephedrineExtended-release Tablets5 mg/120 mgZyrtec-D6/2/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Covington
Baxter
Teva
Fuji
Healthtrust
Boehringer Ingelheim
AstraZeneca
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot